reo
Introduction to reo
Reo is a medication primarily available in tablet form and is used to treat bacterial infections. Reo is effective against respiratory, urinary tract, and skin infections. It is important to note that reo is not effective against viral infections such as the common cold.
Composition of reo
Reo contains the active ingredient Ofloxacin, which is a fluoroquinolone antibiotic. Ofloxacin works by inhibiting bacterial DNA replication, thereby stopping the growth and multiplication of bacteria.
Uses of reo
- Treatment of respiratory infections
- Treatment of urinary tract infections
- Treatment of skin infections
Side effects of reo
- Common side effects: nausea, diarrhea, dizziness
- Serious side effects: tendonitis, tendon rupture
Precautions of reo
Reo can cause tendon damage, including tendonitis and tendon rupture. It is contraindicated in individuals with a history of tendon disorders related to fluoroquinolones. Patients should inform their healthcare provider of any such history before starting reo.
How to Take reo
The usual starting dose for adults is 200 to 400 mg, taken once or twice daily. The maximum recommended dose is 800 mg per day. Reo can be taken with or without food, and the tablet should be swallowed whole. Always follow your doctor’s advice for the correct dosage and method of administration.
Conclusion of reo
Reo, containing the active ingredient Ofloxacin, belongs to the therapeutic class of fluoroquinolone antibiotics. It is primarily used to treat bacterial infections such as respiratory, urinary tract, and skin infections. Manufactured by a reputable pharmaceutical company, reo is a reliable choice for treating these conditions. However, it is crucial to be aware of its potential side effects and contraindications. Always consult your healthcare provider before starting reo to ensure it is the right medication for you.
Similar Medicines
More medicines by Rbs Pharmaceutical
Available in 2 variations

Reo 200mg Tablet
strip of 10 tablets

Reo 400mg Tablet
strip of 10 tablets